program will provide qualifying Medicare hospital inpatient cases with a payment, in addition to the standard-of-care Diagnostic Related Group (DRG) reimbursement, of up to 65% of the cost of AZEDRA for a period of two to three years, effective October 1, 2019.
Notably for medical devices, the IPPS Proposed Rule includes a proposal to revise the calculation of NTAP
for novel drugs and devices from a 50 percent add-on payment to 65 percent, effective FY 2021.
The Vyxeos NTAP
will support Medicare beneficiaries' access to Vyxeos when they are treated in certain inpatient hospital settings.
Summary: NetApp (Nasdaq: NTAP
) announced today its latest EMEA positioning in the open networked disk storage systems market .
The last notable one was when EMC Corp (EMC.N) outbid NetApp Inc (NTAP
.O) last year to buy Data Domain for $2.4 billion.
The Single-Channel 10-Gb Optical nTAP
is a test access port designed to support full-duplex data monitoring up to 20 Gbps.
Network Appliance is particularly active in the Exchange-on-NAS area, since their filers are large and robust, and their built-in NTAP
snapshot technology delivers high levels of data protection that other NAS appliances do not.
), el lider mundial en soluciones de almacenamiento para redes empresariales, esta bajando los costos de almacenamiento a instituciones financieras, producteres de gas y petroleo, proveedores de servicios de telecomunicaciones y a otros mercados verticales de Latinoamerica.
(Nasdaq: LIOX), Waltham, Mass., a provider of multilingual Internet services to global technology businesses, has joined a forum of leading Internet companies, hosted by Akamai Technologies (Nasdaq: AKAM) and Network Appliance (Nasdaq: NTAP
) to create a standards-based protocol for e-services delivery.
) reported fiscal first-quarter results, which beat analyst expectations but NetApp CEO George Kurian acknowledged he's disappointed with the revenue performance -- a sentiment shared by some Street analysts.
(Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today announced that the Centers for Medicare & Medicaid Services (CMS) granted approval for a new technology add-on payment (NTAP
) for ELZONRIS for the treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
The new technology add-on payment (NTAP
) program is a payment system designed by Congress to encourage the uptake of new and costly medical technologies (1) in the hospital setting under the Hospital Inpatient Prospective Payment System (IPPS) in Medicare Part A.